Arteriosclerotic Parkinsonism

Also known as: Parkinsonism Vascular / Vascular Parkinsonism / Vascular parkinsonism (disorder)

Drug	Drug Name	Drug Description
DB00376	Trihexyphenidyl	An antispasmodic drug used as an adjunct drug in the management of parkinsonism and as a treatment for extrapyramidal symptoms caused by drugs affecting the central nervous system (CNS).

Drug	Drug Name	Target	Type
DB00376	Trihexyphenidyl	Muscarinic acetylcholine receptor M1	target
DB00376	Trihexyphenidyl	Muscarinic acetylcholine receptor M2	target
DB00376	Trihexyphenidyl	Muscarinic acetylcholine receptor M3	target
DB00376	Trihexyphenidyl	Muscarinic acetylcholine receptor M4	target
DB00376	Trihexyphenidyl	Muscarinic acetylcholine receptor M5	target
DB00376	Trihexyphenidyl	Serum albumin	carrier

Drug	Drug Name	Phase	Status	Count
DB00399	Zoledronic acid	4	Recruiting	1